Viviane Monges

Viviane Monges currently serves as Independent Director at bioMérieux SA since 2024, Director at Novo Holdings A since 2018, Independent Director at Voluntis SA, Independent Non-Executive Director at ADC Therapeutics SA since 2021, Independent Non-Executive Director at Pharvaris NV since 2021, Director at ADC Technologies, Inc., Director at Ferring BV, and Member-Strategic Board at NeoMedLight SAS since 2014.
Former roles include Chairman at EUROAPI SA from 2021 to 2024, Independent Director at UCB SA, Director at Ferring Holding SA, Independent Director at DBV Technologies SA from 2019 to 2022, Non-Executive Director at Idorsia Ltd. from 2018 to 2021, CFO-Global Pharmaceutical Business at Pfizer Inc. from 2004 to 2006, CFO-Business Excellence Division at Nestlé SA from 2015 to 2017, Global Chief Financial Officer at Novartis AG from 2008 to 2010, Chief Financial Officer at Galderma International SAS, CFO-Business Excellence Division at Nestlé Belgilux SA, Global CFO-Over-the-Counter Division at Novartis Pharma NV from 2008 to 2010, CFO-Global Pharma Business Unit at Wyeth Pharmaceuticals (Belgium) from 2004 to 2006, Group Chief Financial Officer at Galderma Holding SA from 2010 to 2015, and Head-Finance at Renault Asia Pacific Ltd. Education includes undergraduate and MBA degrees from ESCP Europe Campus Paris.